Maxcyte (MXCT) Cash from Operations (2020 - 2026)
Maxcyte (MXCT) posted quarterly Cash from Operations of 8169000.0 for Q1 2026, up 43.31% year-over-year from 5700065.8 in Q1 2025, and down 203.79% quarter-over-quarter from 2689000.0 in Q4 2025.
Maxcyte (MXCT) Cash from Operations (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Cash from Operations for 7 consecutive years, with 8169000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 43.31% year-over-year to 8169000.0; the TTM figure through Mar 2026 stood at 28168000.0 (up 10.46% YoY), while the FY2025 annual figure was 34410000.0, down 24.63% from the prior year.
- Cash from Operations eased to 8169000.0 in Q1 2026 per MXCT's latest filing, from 2689000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 981000.0 in Q4 2023 and bottomed at 14411000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 6274000.0 across 5 years, with a median of 6086400.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations jumped 120.94% — and 2023, when it slumped 1200.04%.
- Maxcyte's Cash from Operations stood at 6086400.0 in 2022, then jumped by 116.12% to 981000.0 in 2023, then slumped by 897.25% to 7821000.0 in 2024, then surged by 65.62% to 2689000.0 in 2025, then slumped by 203.79% to 8169000.0 in 2026.
- Business Quant data shows MXCT's Cash from Operations at 8169000.0 in Q1 2026, 2689000.0 in Q4 2025, and 7458000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | -4.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.66 Mn |
| Jun 30, 2026 | -4.66 Mn |
| Mar 31, 2026 | -8.17 Mn |
| Mar 31, 2026 | -8.17 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Jun 30, 2025 | -9.85 Mn |
| Jun 30, 2025 | -9.85 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Dec 31, 2024 | -7.82 Mn |
| Dec 31, 2024 | -7.82 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -4.83 Mn |
| Mar 31, 2024 | -10.56 Mn |
| Mar 31, 2024 | -10.56 Mn |